斯波真理子 (SHIBA MARIKO) - マイポータル

Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe.

Mariko Harada-Shiba, John J P Kastelein, G Kees Hovingh, Kausik K Ray, Akira Ohtake, Osamu Arisaka, Takao Ohta, Tomoo Okada, Hideki Suganami, Albert Wiegman

Journal of atherosclerosis and thrombosis 25(5) 422-429 2018年5月1日査読有り

Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins

Yukiko Hasegawa, Mika Hori, Tomoko Nakagami, Mariko Harada-Shiba, Yasuko Uchigata

Journal of Clinical Lipidology 12(1) 62-69.e1 2018年1月1日査読有り

Achilles Tendon Ultrasonography for Diagnosis of Familial Hypercholesterolemia Among Japanese Subjects

Masahito Michikura, Masatsune Ogura, Masahiro Yamamoto, Masahiko Sekimoto, Chizuru Fuke, Mika Hori, Koji Arai, Shinji Kihara, Kiminori Hosoda, Koji Yanagi …

CIRCULATION JOURNAL 81(12) 1879-1885 2017年12月査読有り

Familial hypercholesterolaemia

Joep C. Defesche, Samuel S. Gidding, Mariko Harada-Shiba, Robert A. Hegele, Raul D. Santos, Anthony S. Wierzbicki

NATURE REVIEWS DISEASE PRIMERS 3 17093 2017年12月査読有り

Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes

Setoguchi, Kiyoko, Cui, Lin, Hachisuka, Nobutaka, Obchoei, Sumalee, Shinkai, Kentaro, Hyodo, Fuminori, Kato, Kiyoko, Wada, Fumito, Yamamoto, Tsuyoshi, Harada-Shiba, Mariko …

MOLECULAR THERAPY-NUCLEIC ACIDS 9 170-181 2017年12月査読有り

Multimodality assessment of left ventricular dysfunction in Takayasu arteritis and familial hypercholesterolaemia.

Atsushi Okada, Hiroyuki Takahama, Masatsune Ogura, Yoshiaki Morita, Junichi Konma, Shuzo Yoshida, Shigeki Makino, Seiji Takashio, Makoto Amaki, Takahiro Ohara …

ESC heart failure 4(4) 655-659 2017年11月査読有り

LDL apheresis in Japan

Hisashi Makino, Tamiko Tamanaha, Mariko Harada-Shiba

TRANSFUSION AND APHERESIS SCIENCE 56(5) 677-681 2017年10月査読有り

Pathological and molecular analyses of atherosclerotic lesions in ApoE-knockout mice

Masa-Aki Shibata, Eiko Shibata, Kentaro Maemura, Yoichi Kondo, Mariko Harada-Shiba

MEDICAL MOLECULAR MORPHOLOGY 50(3) 130-144 2017年9月査読有り

Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs

Claudia Stefanutti, MIGHTY MEDIC Multinational Society, Ulrich Julius, Gerald F. Watts, Mariko Harada-Shiba, Maria Cossu, Volker J. Schettler, Giustina De Silvestro, Handrean Soran, Jeanine Roeters Van Lennep …

Journal of Clinical Lipidology 11(4) 858-871.e3 2017年7月1日査読有り

A Novel Strategy for Etiologic Factor Removal: Drug-Navigated Clearance System (DNCS)

Atsushi Mahara, Mariko Harada-Shiba, Tetsuji Yamaoka

CHEMICAL & PHARMACEUTICAL BULLETIN 65(7) 649-652 2017年7月査読有り

Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale

Tamio Teramoto, Akira Kondo, Arihiro Kiyosue, Mariko Harada-Shiba, Yasushi Ishigaki, Kimimasa Tobita, Yumiko Kawabata, Asuka Ozaki, Marie T. Baccara-Dinet, Masataka Sata

LIPIDS IN HEALTH AND DISEASE 16(1) 121 2017年6月査読有り

Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study

Masato Nakamura, Kiyoko Uno, Atsushi Hirayama, Junya Ako, Atsushi Nohara, Hidenori Arai, Mariko Harada-Shiba

BMJ OPEN 7(6) e014427 2017年6月査読有り

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study

Frederick J. Raal, G. Kees Hovingh, Dirk Blom, Raul D. Santos, Mariko Harada-Shiba, Eric Bruckert, Patrick Couture, Handrean Soran, Gerald F. Watts, Christopher Kurtz …

LANCET DIABETES & ENDOCRINOLOGY 5(4) 280-290 2017年4月査読有り

Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.

Saito S, Yamamoto Y, Maki T, Hattori Y, Ito H, Mizuno K, Harada-Shiba M, Kalaria RN, Fukushima M, Takahashi R …

Acta neuropathologica communications 5(1) 26 2017年4月査読有り

VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body

Hideaki Yamamoto, Tappei Takada, Yoshihide Yamanashi, Masatsune Ogura, Yusuke Masuo, Mariko Harada-Shiba, Hiroshi Suzuki

SCIENTIFIC REPORTS 7(1) 633 2017年4月査読有り

Mature proprotein convertase subtilisin/kexin type 9, coronary atheroma burden, and vessel remodeling in heterozygous familial hypercholesterolemia

Yu Kataoka, Mariko Harada-Shiba, Kazuhiro Nakao, Takahiro Nakashima, Shoji Kawakami, Masashi Fujino, Tomoaki Kanaya, Toshiyuki Nagai, Yoshio Tahara, Yasuhide Asaumi …

JOURNAL OF CLINICAL LIPIDOLOGY 11(2) 413-421 2017年4月査読有り

Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages

Masato Furuhashi, Masatsune Ogura, Megumi Matsumoto, Satoshi Yuda, Atsuko Muranaka, Mina Kawamukai, Akina Omori, Marenao Tanaka, Norihito Moniwa, Hirofumi Ohnishi …

SCIENTIFIC REPORTS 7(1) 217 2017年3月査読有り

Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia

Mariko Harada-Shiba, Katsunori Ikewaki, Atsushi Nohara, Yoshihiko Otsubo, Koji Yanagi, Masayuki Yoshida, Qing Chang, Pamela Foulds

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS 24(4) 402-411 2017年査読有り

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

Antonio J. Vallejo-Vaz, Asif Akram, Sreenivasa Rao Kondapally Seshasai, Della Cole, Gerald F. Watts, G. Kees Hovingh, John J. P. Kastelein, Pedro Mata, Frederick J. Raal, Raul D. Santos …

ATHEROSCLEROSIS SUPPLEMENTS 22 1-32 2016年12月査読有り

Mild intrauterine hypoperfusion reproduces neurodevelopmental disorders observed in prematurity

Makiko Ohshima, Jacques-Olivier Coq, Kentaro Otani, Yorito Hattori, Yuko Ogawa, Yoshiaki Sato, Mariko Harada-Shiba, Masafumi Ihara, Masahiro Tsuji

SCIENTIFIC REPORTS 6 39377 2016年12月査読有り

斯波真理子

基本情報

論文

メニュー